These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 3278375

  • 1. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
    Hay U, Ludvik B, Gisinger C, Schernthaner G.
    Schweiz Med Wochenschr; 1988 Feb 06; 118(5):165-9. PubMed ID: 3278375
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M, Sagheb MM.
    Ren Fail; 2010 Jan 06; 32(2):172-8. PubMed ID: 20199178
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
    Lewis EJ, Hunsicker LG, Bain RP, Rohde RD.
    N Engl J Med; 1993 Nov 11; 329(20):1456-62. PubMed ID: 8413456
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y.
    N Engl J Med; 1985 Dec 26; 313(26):1617-20. PubMed ID: 3906398
    [Abstract] [Full Text] [Related]

  • 8. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
    Rostoker G, Ben Maadi A, Remy P, Lang P, Lagrue G, Weil B.
    Nephrol Dial Transplant; 1995 Dec 26; 10(1):25-9. PubMed ID: 7724024
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
    Tarnow L, Parving HH, Jacobsen P, Rossing P, Lecerf L, Poirier O, Cambien F.
    Ugeskr Laeger; 1998 Aug 17; 160(34):4886-9. PubMed ID: 9741257
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Aminorroaya A, Janghorbani M, Rezvanian H, Aminian T, Gharavi M, Amini M.
    Nephron Clin Pract; 2005 Aug 17; 99(3):c73-7. PubMed ID: 15665549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
    Komers R, Malý J, Simková R.
    Cas Lek Cesk; 1993 Jun 14; 132(12):359-64. PubMed ID: 8343943
    [Abstract] [Full Text] [Related]

  • 15. Changes in blood pressure and renal function in patients with type I (insulin-dependent) diabetes mellitus prior to clinical diabetic nephropathy.
    Jensen T, Borch-Johnsen K, Deckert T.
    Diabetes Res; 1987 Apr 14; 4(4):159-62. PubMed ID: 3621799
    [Abstract] [Full Text] [Related]

  • 16. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Apr 14; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
    Kopf D, Schmitz H, Beyer J, Frank M, Bockisch A, Lehnert H.
    Diabetes Nutr Metab; 2001 Oct 14; 14(5):245-52. PubMed ID: 11806464
    [Abstract] [Full Text] [Related]

  • 19. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
    J Hypertens; 2006 Nov 14; 24(11):2285-92. PubMed ID: 17053552
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.